[ESTIMATION OF  THYROSTIMULIN RESERVES BY THE NEO-MERCAZOLE TEST].
D000236:Adenoma; D000239:Adenoma, Acidophil; D000238:Adenoma, Chromophobe; D013956:Antithyroid Agents; D002231:Carbimazole; D003397:Craniopharyngioma; D006023:Glycoproteins; D007016:Hypophysectomy; D007018:Hypopituitarism; D007037:Hypothyroidism; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010902:Pituitary Gland; D010911:Pituitary Neoplasms; D010912:Pituitary-Adrenal Function Tests; D013972:Thyrotropin
D013956:Antithyroid Agents; D006023:Glycoproteins; D000451:Mineralocorticoid Receptor Antagonists; C458339:thyrostimulin; D002231:Carbimazole; D013972:Thyrotropin; D008797:Metyrapone
ADENOMA, CHROMOPHOBE; ADENOMA, EOSINOPHILIC; ALDOSTERONE ANTAGONISTS; CRANIOPHARYNGIOMA; HYPOPHYSECTOMY; HYPOPITUITARISM; HYPOTHYROIDISM; METYRAPONE; PITUITARY GLAND; PITUITARY-ADRENAL FUNCTION TESTS; THYROID ANTAGONISTS; THYROTROPIN
APPR'ECIATION DES R'ESERVES EN THYR'EOSTIMULINE PAR LE TEST AU N'EO-MERCAZOLE.